Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02557984Completed
Randomised, double-blind trial in substance use disorder (SUD) comparing Placebo, Amisulpride and Naltrexone (3 arms). Primary endpoints: Cue-Induced Reward Responding Measure at 1 day and Reward Impulsivity Measure at 1 day. Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02557984.